|
1
|
do Pinheiro DR, Ferreira WA, Barros MB,
Araújo MD, Rodrigues-Antunes S and do Borges BN: Perspectives on
new biomarkers in gastric cancer: diagnostic and prognostic
applications. World J Gastroenterol. 20:11574–11585. 2014.
View Article : Google Scholar
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cho JY, Lim JY, Cheong JH, et al: Gene
expression signature-based prognostic risk score in gastric cancer.
Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahn HS, Jeong SH, Son YG, et al: Effect of
neoadjuvant chemotherapy on postoperative morbidity and mortality
in patients with locally advanced gastric cancer. Br J Surg.
101:1560–1565. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahn HS, Lee HJ, Hahn S, et al: Evaluation
of the seventh American Joint Committee on Cancer/International
Union Against Cancer Classification of gastric adenocarcinoma in
comparison with the sixth classification. Cancer. 116:5592–5598.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wittekind C, Compton CC, Greene FL and
Sobin LH: TNM residual tumor classification revisited. Cancer.
94:2511–2516. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC Cancer Staging
Manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Louis P, Hold GL and Flint HJ: The gut
microbiota, bacterial metabolites and colorectal cancer. Nat Rev
Microbiol. 12:661–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong D, Li Y, Wang Z, Banerjee S and
Sarkar FH: Inhibition of angiogenesis and invasion by
3,3′-diindolylmethane is mediated by the nuclear factor-κB
downstream target genes MMP-9 and uPA that regulated
bioavailability of vascular endothelial growth factor in prostate
cancer. Cancer Res. 67:3310–3319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kristal AR and Lampe JW: Brassica
vegetables and prostate cancer risk: a review of the
epidemiological evidence. Nutr Cancer. 42:1–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim J, Cho YA, Choi WJ and Jeong SH:
Gene-diet interactions in gastric cancer risk: a systematic review.
World J Gastroenterol. 20:9600–9610. 2014.PubMed/NCBI
|
|
12
|
Turati F, Pelucchi C, Guercio V, La
Vecchia C and Galeone C: Allium vegetable intake and gastric
cancer: a case-control study and meta-analysis. Mol Nutr Food Res.
Sep 12–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu QJ, Xie L, Zheng W, et al: Cruciferous
vegetables consumption and the risk of female lung cancer: a
prospective study and a meta-analysis. Ann Oncol. 24:1918–1924.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu QJ, Yang Y, Vogtmann E, et al:
Cruciferous vegetables intake and the risk of colorectal cancer: a
meta-analysis of observational studies. Ann Oncol. 24:1079–1087.
2013. View Article : Google Scholar :
|
|
15
|
Wu QJ, Yang Y, Wang J, Han LH and Xiang
YB: Cruciferous vegetable consumption and gastric cancer risk: a
meta-analysis of epidemiological studies. Cancer Sci.
104:1067–1073. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guercio V, Galeone C, Turati F and La
Vecchia C: Gastric cancer and allium vegetable intake: a critical
review of the experimental and epidemiologic evidence. Nutr Cancer.
66:757–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li XJ, Park ES, Park MH and Kim SM:
3,3′-Diindolylmethane suppresses the growth of gastric cancer cells
via activation of the Hippo signaling pathway. Oncol Rep.
30:2419–2426. 2013.PubMed/NCBI
|
|
18
|
Saati GE and Archer MC: Inhibition of
fatty acid synthase and Sp1 expression by 3,3′-diindolylmethane in
human breast cancer cells. Nutr Cancer. 63:790–794. 2011.
View Article : Google Scholar
|
|
19
|
Li XJ, Leem SH, Park MH and Kim SM:
Regulation of YAP through an Akt-dependent process by 3,
3′-diindolylmethane in human colon cancer cells. Int J Oncol.
43:1992–1998. 2013.PubMed/NCBI
|
|
20
|
Kim SJ, Lee JS and Kim SM:
3,3′-Diindolylmethane suppresses growth of human esophageal
squamous cancer cells by G1 cell cycle arrest. Oncol Rep.
27:1669–1673. 2012.PubMed/NCBI
|
|
21
|
Yin XF, Chen J, Mao W, Wang YH and Chen
MH: A selective aryl hydrocarbon receptor modulator
3,3′-diindolylmethane inhibits gastric cancer cell growth. J Exp
Clin Cancer Res. 31:462012. View Article : Google Scholar
|
|
22
|
Wilson MS, Brosens JJ, Schwenen HD and Lam
EW: FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the
outcome of cancer chemotherapy. Curr Drug Targets. 12:1256–1266.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yung MM, Chan DW, Liu VW, Yao KM and Ngan
HY: Activation of AMPK inhibits cervical cancer cell growth through
AKT/FOXO3a/FOXM1 signaling cascade. BMC Cancer. 13:3272013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmad A, Ali S, Wang Z, et al:
3,3′-Diindolylmethane enhances taxotere-induced growth inhibition
of breast cancer cells through downregulation of FoxM1. Int J
Cancer. 129:1781–1791. 2011. View Article : Google Scholar
|
|
25
|
Adami GR and Ye H: Future roles for FoxM1
inhibitors in cancer treatments. Future Oncol. 3:1–3. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Qiu W, Liu B, et al: Forkhead box
transcription factor 1 expression in gastric cancer: FOXM1 is a
poor prognostic factor and mediates resistance to docetaxel. J
Transl Med. 11:2042013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Qi W, Yao R, Tang D and Liang J:
Overexpressed transcription factor FOXM1 is a potential diagnostic
and adverse prognostic factor in postoperational gastric cancer
patients. Clin Transl Oncol. 16:307–314. 2014. View Article : Google Scholar
|
|
28
|
Okada K, Fujiwara Y, Takahashi T, et al:
Overexpression of forkhead box M1 transcription factor (FOXM1) is a
potential prognostic marker and enhances chemoresistance for
docetaxel in gastric cancer. Ann Surg Oncol. 20:1035–1043. 2013.
View Article : Google Scholar
|
|
29
|
Zeng J, Wang L, Li Q, et al: FoxM1 is
up-regulated in gastric cancer and its inhibition leads to cellular
senescence, partially dependent on p27kip1. J Pathol.
218:419–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye S, Lee KB, Park MH, Lee JS and Kim SM:
p63 regulates growth of esophageal squamous carcinoma cells via the
Akt signaling pathway. Int J Oncol. 44:2153–2159. 2014.PubMed/NCBI
|
|
31
|
Lee HH, Ye S, Li XJ, Lee KB, Park MH and
Kim SM: Combination treatment with paclitaxel and doxorubicin
inhibits growth of human esophageal squamous cancer cells by
inactivation of Akt. Oncol Rep. 31:183–188. 2014.
|
|
32
|
Banerjee S, Kong D, Wang Z, Bao B, Hillman
GG and Sarkar FH: Attenuation of multi-targeted
proliferation-linked signaling by 3,3′-diindolylmethane (DIM): from
bench to clinic. Mutat Res. 728:47–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu J, Deshmukh H, Payton JE, et al:
Array-based comparative genomic hybridization identifies CDK4 and
FOXM1 alterations as independent predictors of survival in
malignant peripheral nerve sheath tumor. Clin Cancer Res.
17:1924–1934. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raychaudhuri P and Park HJ: FoxM1: a
master regulator of tumor metastasis. Cancer Res. 71:4329–4333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dai B, Kang SH, Gong W, et al: Aberrant
FoxM1B expression increases matrix metalloproteinase-2
transcription and enhances the invasion of glioma cells. Oncogene.
26:6212–6219. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Z, Park HJ, Carr JR, et al: FoxM1 in
tumorigenicity of the neuroblastoma cells and renewal of the neural
progenitors. Cancer Res. 71:4292–4302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun H, Teng M, Liu J, et al: FOXM1
expression predicts the prognosis in hepatocellular carcinoma
patients after orthotopic liver transplantation combined with the
Milan criteria. Cancer Lett. 306:214–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu N, Jia D, Chen W, et al: FoxM1 is
associated with poor prognosis of non-small cell lung cancer
patients through promoting tumor metastasis. PLoS One.
8:e594122013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qu K, Xu X, Liu C, et al: Negative
regulation of transcription factor FoxM1 by p53 enhances
oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer
Lett. 331:105–114. 2013. View Article : Google Scholar
|
|
40
|
Kalin TV, Wang IC, Ackerson TJ, et al:
Increased levels of the FoxM1 transcription factor accelerate
development and progression of prostate carcinomas in both TRAMP
and LADY transgenic mice. Cancer Res. 66:1712–1720. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chan DW, Yu SY, Chiu PM, et al:
Over-expression of FOXM1 transcription factor is associated with
cervical cancer progression and pathogenesis. J Pathol.
215:245–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lok GT, Chan DW, Liu VW, et al: Aberrant
activation of ERK/FOXM1 signaling cascade triggers the cell
migration/invasion in ovarian cancer cells. PLoS One. 6:e237902011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chan DW, Hui WW, Cai PC, et al: Targeting
GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian
cancer cells. PLoS One. 7:e525782012. View Article : Google Scholar
|
|
44
|
Ahmad A, Wang Z, Kong D, et al: FoxM1
down-regulation leads to inhibition of proliferation, migration and
invasion of breast cancer cells through the modulation of
extra-cellular matrix degrading factors. Breast Cancer Res Treat.
122:337–346. 2010. View Article : Google Scholar
|
|
45
|
Qian J, Luo Y, Gu X, Zhan W and Wang X:
Twist1 promotes gastric cancer cell proliferation through
up-regulation of FoxM1. PLoS One. 8:e776252013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao N, Cheng S, Budhraja A, et al:
3,3′-Diindolylmethane exhibits antileukemic activity in vitro and
in vivo through a Akt-dependent process. PLoS One. 7:e317832012.
View Article : Google Scholar
|
|
47
|
Weng JR, Bai LY, Chiu CF, Wang YC and Tsai
MH: The dietary phytochemical 3,3′-diindolylmethane induces G2/M
arrest and apoptosis in oral squamous cell carcinoma by modulating
Akt-NF-κB, MAPK, and p53 signaling. Chem Biol Interact.
195:224–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ahmad A, Biersack B, Li Y, et al: Targeted
regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and
their derivatives: mechanistic details and biological implications
for cancer therapy. Anticancer Agents Med Chem. 13:1002–1013. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao F and Lam EW: Role of the forkhead
transcription factor FOXO-FOXM1 axis in cancer and drug resistance.
Front Med. 6:376–380. 2012. View Article : Google Scholar : PubMed/NCBI
|
